The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

 
Web www.patentalert.com

< Human cDNAs and proteins and uses thereof

< Amides useful as monoamine re-uptake inhibitors

> Selective NPY (Y5) antagonists

> Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

~ 00233